152 related articles for article (PubMed ID: 10724634)
1. Current considerations in the use of the APTT in monitoring unfractionated heparin.
Nelson DE
Clin Lab Sci; 1999; 12(6):359-64. PubMed ID: 10724634
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.
Spinler SA; Wittkowsky AK; Nutescu EA; Smythe MA
Ann Pharmacother; 2005; 39(7-8):1275-85. PubMed ID: 15956240
[TBL] [Abstract][Full Text] [Related]
3. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
[TBL] [Abstract][Full Text] [Related]
4. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
Olson JD; Arkin CF; Brandt JT; Cunningham MT; Giles A; Koepke JA; Witte DL
Arch Pathol Lab Med; 1998 Sep; 122(9):782-98. PubMed ID: 9740136
[TBL] [Abstract][Full Text] [Related]
5. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
Laposata M; Green D; Van Cott EM; Barrowcliffe TW; Goodnight SH; Sosolik RC
Arch Pathol Lab Med; 1998 Sep; 122(9):799-807. PubMed ID: 9740137
[TBL] [Abstract][Full Text] [Related]
6. Improvement in long-term ECMO by detailed monitoring of anticoagulation: a case report.
Sievert A; Uber W; Laws S; Cochran J
Perfusion; 2011 Jan; 26(1):59-64. PubMed ID: 21057061
[TBL] [Abstract][Full Text] [Related]
7. Monitoring unfractionated heparin with the aPTT: time for a fresh look.
Eikelboom JW; Hirsh J
Thromb Haemost; 2006 Nov; 96(5):547-52. PubMed ID: 17080209
[TBL] [Abstract][Full Text] [Related]
8. Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations.
Marlar RA; Clement B; Gausman J
Semin Thromb Hemost; 2017 Apr; 43(3):253-260. PubMed ID: 27272964
[TBL] [Abstract][Full Text] [Related]
9. The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
Rosenberg AF; Zumberg M; Taylor L; LeClaire A; Harris N
J Pharm Pract; 2010 Jun; 23(3):210-6. PubMed ID: 21507816
[TBL] [Abstract][Full Text] [Related]
10. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
Toulon P; Ajzenberg N; Smahi M; Guillin MC
Thromb Res; 2007; 119(2):135-43. PubMed ID: 16426667
[TBL] [Abstract][Full Text] [Related]
11. Monitoring the anti-Xa anticoagulants, from heparin to eliquis.
Fritsma GA
Clin Lab Sci; 2013; 26(1):48-53. PubMed ID: 23479837
[No Abstract] [Full Text] [Related]
12. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
Hull RD; Pineo GF
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
[TBL] [Abstract][Full Text] [Related]
13. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
Greaves M;
Thromb Haemost; 2002 Jan; 87(1):163-4. PubMed ID: 11848446
[No Abstract] [Full Text] [Related]
14. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anticoagulation efficacy and clinical safety between imported and domestically manufactured low-molecular-weight heparin during hemodialysis.
Liu ZQ; Wang L
Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):942-3. PubMed ID: 12377628
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic monitoring of unfractionated heparin - trials and tribulations.
Baluwala I; Favaloro EJ; Pasalic L
Expert Rev Hematol; 2017 Jul; 10(7):595-605. PubMed ID: 28632418
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the standard pediatric unfractionated heparin dosing protocol.
Al Obary EE; Al-Jazairi AS; Zaghloul IM; Saleh MM; Al Musa AS; Al-Halees Z
Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):153-9. PubMed ID: 22499962
[TBL] [Abstract][Full Text] [Related]
18. Inaccuracy of a "spiked curve" for monitoring unfractionated heparin therapy.
Gausman JN; Marlar RA
Am J Clin Pathol; 2011 Jun; 135(6):870-6. PubMed ID: 21571960
[TBL] [Abstract][Full Text] [Related]
19. Heparin therapy: current regimens and principles of monitoring.
Berry BR; Nantel S
Postgrad Med; 1996 Jun; 99(6):64-6, 69-76. PubMed ID: 8668639
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring of heparin therapy].
Camici M; Evangelisti L
Minerva Med; 1993 Oct; 84(10):507-9. PubMed ID: 8247304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
